...
首页> 外文期刊>Acta pharmaceutica sciencia >Development and Characterization of Floating Alginate Beads for Gastroretentive Drug Delivery System
【24h】

Development and Characterization of Floating Alginate Beads for Gastroretentive Drug Delivery System

机译:胃滞留给药系统漂浮藻酸盐微珠的研制与表征

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The main object of this study was to involve in development and characterization of novel floating alginate beads of Ranitidine HC1 having an air compartment in itself to increase its residence time in the stomach without contact with mucosa. Such floating alginate beads were prepared by Ion-gelation method, using various ratio of CaCl_2 as a crosslinking agent in ion gelation media. The presence of air compartment was observed in formulation FF_1, FF_2 and CFF_3, CFF_6 by visual examination but only FFj and CFF_3 were found to be buoyant. Average particle size of the formulation FF_1 and CFF_3 were found to be 1.36+- 0.28 mm and 1.45+-0.21 mm respectively. Surface morphology of formulations FF_1 and CFF_3 before and after complete dissolution test were studied by Scanning electron microscopy (SEM). In-vitro drug release studies of selected formulations were performed in 900 ml simulated gastric fluid (1.2 pH) without pepsin. Different drug release kinetics models were also applied for selected batches.
机译:这项研究的主要目的是开发和表征雷尼替丁HC1的新型漂浮藻酸盐珠,其本身具有空气隔室,以增加其在胃中的停留时间而不与粘膜接触。通过离子胶凝法,使用各种比例的CaCl_2作为离子胶凝介质中的交联剂,通过离子胶凝法制备此类漂浮藻酸盐珠。通过目测观察到制剂FF_1,FF_2和CFF_3,CFF_6中存在空气隔室,但是仅发现FFj和CFF_3是浮力的。发现制剂FF_1和CFF_3的平均粒径分别为1.36±0.28mm和1.45±0.21mm。通过扫描电子显微镜(SEM)研究了制剂FF_1和CFF_3在完全溶解测试之前和之后的表面形态。在不含胃蛋白酶的900 ml模拟胃液(1.2 pH)中进行了选定制剂的体外药物释放研究。不同的药物释放动力学模型也适用于选定的批次。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号